First Berlin – Pharming Group NV Research Update (22/07/2026)
First Berlin Equity Research has published a research update on Pharming Group NV (ISIN: NL0010391025). Analyst Simon Scholes reiterated his [...]
First Berlin – Pharming Group NV Research Update (22.07.2026)
First Berlin Equity Research hat ein Research Update zu Pharming Group NV (ISIN: NL0010391025) veröffentlicht. Analyst Simon Scholes bestätigt seine [...]
First Berlin – ad pepper media International N.V. Research Update (22.07.2026)
First Berlin Equity Research hat ein Research Update zu ad pepper media International N.V. (ISIN: NL0000238145) veröffentlicht. Analyst Dr. Karsten [...]
First Berlin – ad pepper media International N.V. Research Update (22/07/2026)
First Berlin Equity Research has published a research update on ad pepper media International N.V. (ISIN: NL0000238145). Analyst Dr. Karsten [...]
First Berlin – Cardiol Therapeutics Inc. Research Update (20.07.2026)
First Berlin Equity Research hat ein Research Update zu Cardiol Therapeutics Inc. (ISIN: CA14161Y2006) veröffentlicht. Analyst Christian Orquera bestätigt seine [...]
First Berlin – Cardiol Therapeutics Inc. Research Update (20/07/2026)
First Berlin Equity Research has published a research update on Cardiol Therapeutics Inc. (ISIN: CA14161Y2006). Analyst Christian Orquera reiterated his [...]
First Berlin – Marinomed Biotech AG Research Update (20.07.2026)
First Berlin Equity Research hat ein Research Update zu Marinomed Biotech AG (ISIN: ATMARINOMED6) veröffentlicht (korrigierte Version). Analyst Alexander Rihane [...]
First Berlin – Marinomed Biotech AG Research Update (20/07/2026)
First Berlin Equity Research has published a research update (corrected version) on Marinomed Biotech AG (ISIN: ATMARINOMED6). Analyst Alexander Rihane [...]
First Berlin – CEL-SCI Corporation Research Update (20.07.2026)
First Berlin Equity Research hat ein Research Update zu CEL-SCI Corporation (ISIN: US1508376076) veröffentlicht. Analyst Christian Orquera bestätigt seine BUY-Empfehlung [...]
First Berlin – CEL-SCI Corporation Research Update (20/07/2026)
First Berlin Equity Research has published a research update on CEL-SCI Corporation (ISIN: US1508376076). Analyst Christian Orquera reiterated his BUY [...]
Didn’t find what you’re looking for?
If you have unanswered questions about our services and are classified as an institutional investor, contact us to see how we can service your institution.

Stay In Touch